Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kei Kuroda

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
The Journal of Investigative Dermatology|April 23, 2004
Type II collagen accumulation in overlying dermo-epidermal junction of pilomatricoma is mediated by bone morphogenetic protein 2 and 4Hideki Mieno, Kei Kuroda, Hiroshi Shinkai, et al.
The Journal of Investigative Dermatology|December 2, 2006
Accumulation of elafin in actinic elastosis of sun-damaged skin: elafin binds to elastin and prevents elastolytic degradationJun Muto, Kei Kuroda, Hiroshi Wachi, et al.
JACC. Case Reports|July 28, 2021
Myocardial Vasculitis Associated With the Immune Checkpoint Inhibitor PembrolizumabHideo Oishi, Ryota Morimoto, Yoshie Shimoyama, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
The Journal of Investigative Dermatology|April 23, 2004
Type II collagen accumulation in overlying dermo-epidermal junction of pilomatricoma is mediated by bone morphogenetic protein 2 and 4Hideki Mieno, Kei Kuroda, Hiroshi Shinkai, et al.
The Journal of Investigative Dermatology|December 2, 2006
Accumulation of elafin in actinic elastosis of sun-damaged skin: elafin binds to elastin and prevents elastolytic degradationJun Muto, Kei Kuroda, Hiroshi Wachi, et al.
JACC. Case Reports|July 28, 2021
Myocardial Vasculitis Associated With the Immune Checkpoint Inhibitor PembrolizumabHideo Oishi, Ryota Morimoto, Yoshie Shimoyama, et al.
Pageof 2